THE PERVASIVE IMPACT OF PRURITUS ON QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): REAL WORLD EXPERIENCE IN TARGET-PBC

被引：0

作者：

Carey, Elizabeth J. ^{[1
]}

Smith, Helen ^{[2
]}

McLaughlin, Megan ^{[2
]}

Thompson, April ^{[2
]}

Mospan, Andrea ^{[3
]}

Sandefur, Robert A. ^{[3
]}

Zink, Richard C. ^{[3
]}

Kim, W. Ray ^{[4
]}

Levy, Cynthia ^{[5
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Scottsdale, AZ USA

[2] GSK, Res & Dev, Brentford, England

[3] Target Pharmasolut Inc, Durham, NC USA

[4] Stanford Univ, Med, Stanford, CA 94305 USA

[5] Univ Miami, Miami, FL USA

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1276

引用

页码：766A / 767A

页数：2

共 50 条

[21] Implementation of a national registry for patients with primary biliary cholangitis (PBC): The German PBC cohort
Wiegand, Johannes
Stein, Kerstin
Guenther, Rainer
Naumann, Uwe
Zimny, Sebastian
Reuken, Philipp
Boettler, Tobias
Bantel, Heike
Hofmann, Wolf Peter
Kremer, Andreas E.
Kautz, Achim
Beuers, Ulrich
Trautwein, Christian
Franke, Annegret
Piotrowski, Katja
Berg, Thomas
JOURNAL OF HEPATOLOGY, 2021, 75 : S429 - S430
[22] IDENTIFYING DRIVERS OF PATIENT (PT) PREFERENCE IN THE TREATMENT OF PRURITUS IN PRIMARY BILIARY CHOLANGITIS (PBC)
Halliday, Anna
Smith, Helen T.
Szinay, Dorothy
Walker, Andy
Meginnis, Keila
Heidenreich, Sebastian
Seo, Jaein
HEPATOLOGY, 2023, 78 : S2051 - S2052
[23] Primary biliary cholangitis-Autoimmune hepatitis overlap syndrome: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort
Mayo, Marlyn J.
Bowlus, Christopher
Carey, Elizabeth
Little, Ester
Deane, Karen
Zink, Richard
Sandefur, Robert
Kim, W. Ray
Levy, Cynthia
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E403 - E403
[24] THE IMPACT OF PRIMARY BILIARY CIRRHOSIS (PBC) ON PERCEIVED QUALITY OF LIFE (QoL): THE UK-PBC NATIONAL STUDY
Mells, G.
Pells, G.
Newton, J.
Bathgate, A.
Burroughs, A.
Heneghan, M.
Neuberger, J.
Day, D.
Ducker, S.
Sandford, R.
Alexander, G.
Jones, D.
JOURNAL OF HEPATOLOGY, 2013, 58 : S392 - S392
[25] A Real World Experience of Obeticholic Acid (OCA) Therapy in Patients with Primary Biliary Cholangitis (PBC) Treated in a Tertiary Care Liver Center
Yimam, Kidist K.
Gebremedhin, Saba E.
Frederick, Richard Todd
Davem, Timothy J.
Holt, Edward W.
Merriman, Raphael B.
Cooper, Stewart
Sherman, Courtney
Wakil, Adil Ed
Ho, Chanda K.
Guy, Jennifer E.
HEPATOLOGY, 2018, 68 : 1094A - 1094A
[26] Examination of Canadian Primary Biliary Cholangitis (PBC) patients by conventional and novel PBC- specific biomarkers
Norman, Gary L.
Shums, Zakera
Encabo, Susan
Milo, Jay
Mahler, Michael
Swain, Mark G.
Mason, Andrew
Baeza, Natalia
Fritzler, Marvin J.
HEPATOLOGY, 2016, 64 : 196A - 197A
[27] PRURITUS IMPACTS HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND SLEEP FOR PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) IN THE PATIENT-CENTRIC PICNICHEALTH REGISTRY
Halliday, Anna
Gibbons, Daniel
Abner, Sophia
Friedler, Haley
Dhirishiya, P.
Vadlamudi, Harini
Earley-Valovic, Veronika
Levy, Cynthia
HEPATOLOGY, 2024, 80 : S1778 - S1779
[28] PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis
Alrubaiy, Laith
Mells, George
Flack, Steven
Bosomworth, Helen
Hutchings, Hayley
Williams, John
Jones, David
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (11-12) : 1223 - 1231
[29] Impact of fatigue and the irritable bowel syndrome on the quality of life in patients with primary biliary cirrhosis (PBC).
Bjornsson, E
Simren, M
Olsson, R
HEPATOLOGY, 2002, 36 (04) : 423A - 423A
[30] Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)
Kaps, Leonard
Grambihler, Annette
Yemane, Bethlehem
Nagel, Michael
Labenz, Christian
Ploch, Pascal
Michel, Maurice
Galle, Peter R.
Woerns, Marcus-Alexander
Schattenberg, Joern M.
DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (10) : 3006 - 3013

← 1 2 3 4 5 →